Ligand-Modified Aminobisphosphonate for Linking Proteins to Hydroxyapatite and Bone Surface

详细信息    查看全文

• 作者：Robin S. Ehrick ; Marcello Capaccio ; David A. Puleo ; Leonidas G. Bachas
• 刊名：Bioconjugate Chemistry
• 出版年：2008
• 出版时间：January 2008
• 年：2008
• 卷：19
• 期：1
• 页码：315 - 321
• 全文大小：623K
• 年卷期：v.19,no.1(January 2008)
• ISSN：1520-4812

文摘

An increase in bone resorption is one of the main symptoms of osteoporosis, a disease that affects more and more individuals every day. Bisphosphonates are known to inhibit bone resorption and thus are being used as a treatment for osteoporosis. Aminobisphosphonates present a functionality that can be easily used for conjugation to other molecules, such as peptides, proteins, and ligands for protein recognition. In this study, an aminobisphosphonate conjugated with biotin was used as a model linker for protein attachment to bone. With this system, the interaction of biotinylated aminobisphosphonate with hydroxyapatite, a major mineral component of bone, was investigated. Quantification of the binding of aminobisphosphonate to hydroxyapatite was performed using a fluorescently labeled antibody for biotin. Additionally, the interaction of the biotinylated aminobisphosphonate with multiple treatments of cortical bone from the midshaft of a cow femur was studied. It was demonstrated that modified aminobisphosphonate reagents can bind hydroxyapatite and bone at high levels, while the biotin functionality is free to be recognized by the fluorescently labeled antibiotin antibody, suggesting that modified aminobisphosphonates could be used to link other peptides or proteins to the bone surface.